Clinical Trial

AMD and Validation Rod-Meditated Dark Adaptation With Everyday Task Performance

Recruiting
View on ClinicalTrials.gov →
Summary
The goal is to conduct a cross-sectional, single timepoint study on older adults with early and intermediate AMD, and with subretinal drusenoid deposits (SDD), and those in normal health, establishing an association between dark adaptation and reading performance under dim illumination, both which depend on rod photoreceptors.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-12-31 -> 2027-12-31 2026-08-11
minor Completion pushed: 2027-12-31 -> 2028-01-31 2026-08-11
Trial Details
NCT Number NCT06619405
Lead Sponsor Duke University
Collaborators: Boehringer Ingelheim, StreetLab Vision
Conditions Age-Related Macular Degeneration
Enrollment 100 participants
Start Date 2025-08-15
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-10